Lista de obras -

A Cell Culture-Derived Influenza Vaccine Provides Consistent Protection Against Infection and Reduces the Duration and Severity of Disease in Infected Individuals ⬇️

artículo científico publicado el 19 de enero de 2012

A Vero Cell–Derived Whole-Virus H5N1 Vaccine Effectively Induces Neuraminidase-Inhibiting Antibodies ⬇️

artículo científico publicado el 16 de noviembre de 2011

A cell culture (Vero)-derived H5N1 whole-virus vaccine induces cross-reactive memory responses.

artículo científico publicado en 2009

A clinical trial of a whole-virus H5N1 vaccine derived from cell culture.

artículo científico publicado en 2008

A close look at human IgG sialylation and subclass distribution after lectin fractionation

artículo científico publicado en 2009

A non-adjuvanted whole-virus H1N1 pandemic vaccine is well tolerated and highly immunogenic in children and adolescents and induces substantial immunological memory

artículo científico publicado el 28 de julio de 2012

A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans

artículo científico publicado en 2011

A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models.

artículo científico publicado en 2010

Activated protein C: more effective than nonactivated protein C?

scientific article published on 01 May 2003

Adjuvanted or whole-virion vaccine for 2009 influenza A (H1N1)

artículo científico publicado en 2011

Anti-amyloidogenic activity of IgGs contained in normal plasma

artículo científico publicado en 2010

Antibody persistence after two vaccinations with either FSME-IMMUN® Junior or ENCEPUR® Children followed by third vaccination with FSME-IMMUN® Junior.

artículo científico publicado en 2012

Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1 influenza vaccine induces long-lasting cross-reactive memory immune response: homologous or heterologous booster response following two dose or single dose priming.

artículo científico publicado en 2012

Clinical development of a Vero cell culture-derived seasonal influenza vaccine ⬇️

artículo científico publicado el 13 de diciembre de 2011

Clinical evaluation to determine the appropriate paediatric formulation of a tick-borne encephalitis vaccine

artículo científico publicado en 2010

Comparison of immunogenicity and safety between two paediatric TBE vaccines.

artículo científico publicado en 2010

Comparison of plasma-derived and recombinant von Willebrand factor by atomic force microscopy.

artículo científico publicado en 2010

Developing cell culture-derived pandemic vaccines.

artículo científico publicado en 2010

Efficacy and physiological effects of human butyrylcholinesterase as a post-exposure therapy against percutaneous poisoning by VX in the guinea-pig

artículo científico publicado en 2010

Efficacy, safety and tolerability of a new 10% liquid intravenous immune globulin [IGIV 10%] in patients with primary immunodeficiency

artículo científico publicado en 2006

Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial ⬇️

artículo científico publicado el 15 de febrero de 2011

Ethanol dependence of alpha 1-antitrypsin C-terminal Lys truncation mediated by basic carboxypeptidases

artículo científico publicado en 2007

Evaluation of the cellular immune responses induced by a non-adjuvanted inactivated whole virus A/H5N1/VN/1203 pandemic influenza vaccine in humans.

artículo científico publicado en 2010

Glycoproteomic characterization of butyrylcholinesterase from human plasma

artículo científico publicado en 2008

Group C meningococcal polysaccharide-tetanus toxoid conjugate vaccine: a meta-analysis of immunogenicity, safety and posology

artículo científico publicado en 2005

H5N1 whole-virus vaccine induces neutralizing antibodies in humans which are protective in a mouse passive transfer model

artículo científico publicado en 2011

History of TBE vaccines

artículo científico publicado en 2003

Human anti-Aβ IgGs target conformational epitopes on synthetic dimer assemblies and the AD brain-derived peptide

artículo científico publicado en 2012

Human anti-macrophage migration inhibitory factor antibodies inhibit growth of human prostate cancer cells in vitro and in vivo

artículo científico publicado en 2013

Hyperimmune intravenous immunoglobulin containing high titers of pandemic H1N1 hemagglutinin and neuraminidase antibodies provides dose-dependent protection against lethal virus challenge in SCID mice

artículo científico publicado en 2014

Integrated analysis of safety and efficacy of a plasma- and albumin-free recombinant factor VIII (rAHF-PFM) from six clinical studies in patients with hemophilia A

article

Neutralization of macrophage migration inhibitory factor (MIF) by fully human antibodies correlates with their specificity for the β-sheet structure of MIF.

artículo científico publicado en 2012

Only activated protein C treatment and not protein C has demonstrated an improvement in survival in severe sepsis

scientific article published on 01 February 2004

Pharmacokinetics and tolerability of ABX464, a novel first-in-class compound to treat HIV infection, in healthy HIV-uninfected subjects

artículo científico publicado en 2016

Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.

artículo científico publicado en 2012

Preclinical testing of human recombinant von Willebrand factor: ADAMTS13 cleavage capacity in animals as criterion for species suitability

artículo científico publicado en 2010

Preparation of commercial quantities of a hyperimmune human intravenous immunoglobulin preparation against an emerging infectious disease: the example of pandemic H1N1 influenza ⬇️

artículo científico publicado el 7 de octubre de 2011

Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programme.

artículo científico

RNA sequencing analysis of activated macrophages treated with the anti-HIV ABX464 in intestinal inflammation

artículo científico publicado en 2017

Randomized Trial of Food Effect on Pharmacokinetic Parameters of ABX464 Administered Orally to Healthy Male Subjects

scientific article published on 31 October 2016

Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity ⬇️

artículo científico publicado el 12 de diciembre de 2003

Re: Tick-borne encephalitis (TBE) trends in epidemiology and current and future management

artículo científico publicado en 2011

Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial.

artículo científico publicado en 2013

Safety and immunogenicity of a vero cell culture-derived whole-virus H5N1 influenza vaccine in chronically ill and immunocompromised patients

artículo científico publicado en 2014

Safety and immunogenicity of a vero cell culture-derived whole-virus influenza A(H5N1) vaccine in a pediatric population.

artículo científico publicado en 2013

Safety and immunogenicity of an inactivated whole virus Vero cell-derived Ross River virus vaccine: a randomized trial

artículo científico publicado en 2011

Safety and immunogenicity of two different doses of a Vero cell-derived, whole virus clade 2 H5N1 (A/Indonesia/05/2005) influenza vaccine

artículo científico publicado en 2011

Safety, Pharmacokinetics, and Antiviral Activity of a Novel HIV Antiviral, ABX464, in Treatment-Naive HIV-Infected Subjects in a Phase 2 Randomized, Controlled Study

artículo científico publicado en 2017

Safety, tolerability and impact on viral reservoirs of the addition to antiretroviral therapy of ABX464, an investigational antiviral drug, in individuals living with HIV-1: a Phase IIa randomised controlled study

article

Selective Targeting of a Disease-Related Conformational Isoform of Macrophage Migration Inhibitory Factor Ameliorates Inflammatory Conditions.

artículo científico publicado en 2015

Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18-67 years

artículo científico publicado en 2009

Single priming dose of meningococcal group C conjugate vaccine (NeisVac-C®) in infants

artículo científico publicado en 2013

Small Peptides Blocking Inhibition of Factor Xa and Tissue Factor-Factor VIIa by Tissue Factor Pathway Inhibitor (TFPI)

artículo científico publicado en 2014

Structure and function of a recombinant von Willebrand factor drug candidate

artículo científico publicado en 2010

The Anti-Hiv Candidate Abx464 Dampens Intestinal Inflammation by Triggering Il-22 Production in Activated Macrophages

artículo científico publicado en 2017

The influence of carrier protein on the immunogenicity of simultaneously administered conjugate vaccines in infants

artículo científico publicado en 2009

Tolerability of modified tick-borne encephalitis vaccine FSME-IMMUN "NEW" in children: results of post-marketing surveillance

artículo científico publicado en 2003

Vectors Based on Modified Vaccinia Ankara Expressing Influenza H5N1 Hemagglutinin Induce Substantial Cross-Clade Protective Immunity ⬇️

artículo científico publicado el 24 de enero de 2011

Vero cell culture-derived pandemic influenza vaccines: preclinical and clinical development

artículo científico publicado en 2013

Lista de obras de

A Cell Culture-Derived Influenza Vaccine Provides Consistent Protection Against Infection and Reduces the Duration and Severity of Disease in Infected Individuals ⬇️

A Vero Cell–Derived Whole-Virus H5N1 Vaccine Effectively Induces Neuraminidase-Inhibiting Antibodies ⬇️

A cell culture (Vero)-derived H5N1 whole-virus vaccine induces cross-reactive memory responses.

A clinical trial of a whole-virus H5N1 vaccine derived from cell culture.

A close look at human IgG sialylation and subclass distribution after lectin fractionation

A non-adjuvanted whole-virus H1N1 pandemic vaccine is well tolerated and highly immunogenic in children and adolescents and induces substantial immunological memory

A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans

A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models.

Activated protein C: more effective than nonactivated protein C?

Adjuvanted or whole-virion vaccine for 2009 influenza A (H1N1)

Anti-amyloidogenic activity of IgGs contained in normal plasma

Antibody persistence after two vaccinations with either FSME-IMMUN® Junior or ENCEPUR® Children followed by third vaccination with FSME-IMMUN® Junior.

Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1 influenza vaccine induces long-lasting cross-reactive memory immune response: homologous or heterologous booster response following two dose or single dose priming.

Clinical development of a Vero cell culture-derived seasonal influenza vaccine ⬇️

Clinical evaluation to determine the appropriate paediatric formulation of a tick-borne encephalitis vaccine

Comparison of immunogenicity and safety between two paediatric TBE vaccines.

Comparison of plasma-derived and recombinant von Willebrand factor by atomic force microscopy.

Developing cell culture-derived pandemic vaccines.

Efficacy and physiological effects of human butyrylcholinesterase as a post-exposure therapy against percutaneous poisoning by VX in the guinea-pig

Efficacy, safety and tolerability of a new 10% liquid intravenous immune globulin [IGIV 10%] in patients with primary immunodeficiency

Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial ⬇️

Ethanol dependence of alpha 1-antitrypsin C-terminal Lys truncation mediated by basic carboxypeptidases

Evaluation of the cellular immune responses induced by a non-adjuvanted inactivated whole virus A/H5N1/VN/1203 pandemic influenza vaccine in humans.

Glycoproteomic characterization of butyrylcholinesterase from human plasma

Group C meningococcal polysaccharide-tetanus toxoid conjugate vaccine: a meta-analysis of immunogenicity, safety and posology

H5N1 whole-virus vaccine induces neutralizing antibodies in humans which are protective in a mouse passive transfer model

History of TBE vaccines

Human anti-Aβ IgGs target conformational epitopes on synthetic dimer assemblies and the AD brain-derived peptide

Human anti-macrophage migration inhibitory factor antibodies inhibit growth of human prostate cancer cells in vitro and in vivo

Hyperimmune intravenous immunoglobulin containing high titers of pandemic H1N1 hemagglutinin and neuraminidase antibodies provides dose-dependent protection against lethal virus challenge in SCID mice

Integrated analysis of safety and efficacy of a plasma- and albumin-free recombinant factor VIII (rAHF-PFM) from six clinical studies in patients with hemophilia A

Neutralization of macrophage migration inhibitory factor (MIF) by fully human antibodies correlates with their specificity for the β-sheet structure of MIF.

Only activated protein C treatment and not protein C has demonstrated an improvement in survival in severe sepsis

Pharmacokinetics and tolerability of ABX464, a novel first-in-class compound to treat HIV infection, in healthy HIV-uninfected subjects

Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.

Preclinical testing of human recombinant von Willebrand factor: ADAMTS13 cleavage capacity in animals as criterion for species suitability

Preparation of commercial quantities of a hyperimmune human intravenous immunoglobulin preparation against an emerging infectious disease: the example of pandemic H1N1 influenza ⬇️

Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programme.

RNA sequencing analysis of activated macrophages treated with the anti-HIV ABX464 in intestinal inflammation

Randomized Trial of Food Effect on Pharmacokinetic Parameters of ABX464 Administered Orally to Healthy Male Subjects

Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity ⬇️

Re: Tick-borne encephalitis (TBE) trends in epidemiology and current and future management

Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial.

Safety and immunogenicity of a vero cell culture-derived whole-virus H5N1 influenza vaccine in chronically ill and immunocompromised patients

Safety and immunogenicity of a vero cell culture-derived whole-virus influenza A(H5N1) vaccine in a pediatric population.

Safety and immunogenicity of an inactivated whole virus Vero cell-derived Ross River virus vaccine: a randomized trial

Safety and immunogenicity of two different doses of a Vero cell-derived, whole virus clade 2 H5N1 (A/Indonesia/05/2005) influenza vaccine

Safety, Pharmacokinetics, and Antiviral Activity of a Novel HIV Antiviral, ABX464, in Treatment-Naive HIV-Infected Subjects in a Phase 2 Randomized, Controlled Study

Safety, tolerability and impact on viral reservoirs of the addition to antiretroviral therapy of ABX464, an investigational antiviral drug, in individuals living with HIV-1: a Phase IIa randomised controlled study

Selective Targeting of a Disease-Related Conformational Isoform of Macrophage Migration Inhibitory Factor Ameliorates Inflammatory Conditions.

Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18-67 years

Single priming dose of meningococcal group C conjugate vaccine (NeisVac-C®) in infants

Small Peptides Blocking Inhibition of Factor Xa and Tissue Factor-Factor VIIa by Tissue Factor Pathway Inhibitor (TFPI)

Structure and function of a recombinant von Willebrand factor drug candidate

The Anti-Hiv Candidate Abx464 Dampens Intestinal Inflammation by Triggering Il-22 Production in Activated Macrophages

The influence of carrier protein on the immunogenicity of simultaneously administered conjugate vaccines in infants

Tolerability of modified tick-borne encephalitis vaccine FSME-IMMUN "NEW" in children: results of post-marketing surveillance

Vectors Based on Modified Vaccinia Ankara Expressing Influenza H5N1 Hemagglutinin Induce Substantial Cross-Clade Protective Immunity ⬇️

Vero cell culture-derived pandemic influenza vaccines: preclinical and clinical development